Pressemeddelelse
Hamlet BioPharma AB (publ): Monthly investor meeting on the 22nd of May when Hamlet BioPharma is releasing it's Q3 report
Hamlet BioPharma invites you to the investors' meeting to be held on the 22nd of May 2026, at 12:00.
Please click on the link below to participate in the meeting
https://youtube.com/live/3TgHDRRadfk?feature=share
For further information, please contact
Catharina Svanborg, Chairman of the Board, Hamlet BioPharma AB, +46 709 42 65 49,
catharina.svanborg@hamletpharma.com
Jakob Testad, CEO, Hamlet BioPharma AB, +46 708 48 42 10,
jakob.testad@hamletbiopharma.com